Reversibility of Brainstem Evoked Response Audiometry Abnormalities at 3 Months in Term Newborns with Hyperbilirubinemia.

dc.contributor.authorVinodh, M
dc.contributor.authorAmbikapathy, P
dc.contributor.authorAravind, M A
dc.contributor.authorGanesh, J
dc.date.accessioned2016-01-07T10:40:38Z
dc.date.available2016-01-07T10:40:38Z
dc.date.issued2014-02
dc.description.abstractBackground: High bilirubin level is toxic to developing brain and auditory system but the current debate surrounds the toxicity of bilirubin in healthy term infants. Methods: Longitudinal observational study to find BERA abnormalities in term newborns with isolated hyperbilirubinemia of 20 mg/dL and more and to follow up babies at 3 months to find out about the reversibility in BERA abnormalities noted at birth. Results: BERA abnormalities were present in 17.64% of babies with isolated hyperbilirubinemia at discharge. There was a reversibility of BERA abnormalities in 61.61% during follow up. Conclusion: BERA abnormalities are reversible in term neonates with hyperbilirubinemia.en_US
dc.identifier.citationVinodh M, Ambikapathy P, Aravind M A, Ganesh J. Reversibility of Brainstem Evoked Response Audiometry Abnormalities at 3 Months in Term Newborns with Hyperbilirubinemia. Indian Pediatrics. 2014 February; 51(2): 134-135.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/170180
dc.language.isoenen_US
dc.source.urihttps://www.indianpediatrics.net/feb2014/feb-134-135.htmen_US
dc.subjectBERAen_US
dc.subjectHearingen_US
dc.subjectFollow-upen_US
dc.subjectOutcomeen_US
dc.subjectTerm neonatesen_US
dc.titleReversibility of Brainstem Evoked Response Audiometry Abnormalities at 3 Months in Term Newborns with Hyperbilirubinemia.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ip2014v51n2p134.pdf
Size:
20.27 KB
Format:
Adobe Portable Document Format
Description:
Research brief
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: